To identify specific factors that might guide future quality-improvement initiatives (i.e., further improve basal-bolus insulin use and decrease the incidence of hyperglycemia), we conducted an analysis of the available data to determine factors correlated with glucose control and basal-bolus insulin therapy. This evidence concerns the gene INS and Hyperglycemia.